Annual report pursuant to Section 13 and 15(d)

Note 7 - Goodwill and Other Intangible Assets (Tables)

v3.7.0.1
Note 7 - Goodwill and Other Intangible Assets (Tables)
 12 Months Ended
Dec. 31, 2016
Notes Tables  
Schedule of Goodwill [Table Text Block]
   
2015
  
   
January 1,
    
Additions
    
Adjustments
    
Impairments
    
December 31,
  
RedPath
   $
15,545
     $
—
     $
121
     $
(15,666
)
   $
—
  
                                         
Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]
           
As of December 31, 2016
    
As of December 31, 2015
  
   
Life
    
Carrying
    
Carrying
  
   
(Years)
    
Amount
    
Amount
  
Diagnostic assets:
 
 
 
 
 
 
 
 
 
 
 
 
Asuragen acquisition:
                        
Thyroid
    
9
     $
8,519
    $
8,519
 
Pancreas
    
-
     
-
     
2,882
 
Biobank
    
-
     
-
     
1,575
 
RedPath acquisition:
                        
Pancreas test
    
7
      
16,141
     
16,141
 
Barrett's test
    
9
      
18,351
     
18,351
 
Total
    
 
     $
43,011
    $
47,468
 
Diagnostic lab:
 
 
 
 
 
 
 
 
 
 
 
 
CLIA Lab
    
2.3
     $
609
    $
609
 
                         
Accumulated Amortization
    
 
     $
(7,262
 )   $
(4,585
 )
                         
Net Carrying Value
    
 
     $
36,358
    $
43,492
 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
2017
    
2018
    
2019
    
2020
    
2021
  
$ 4,272     $
5,292
    $
5,292
    $
5,292
    $
4,908